Author:
Lustberg Maryam B.,Pant Shubham,Ruppert Amy S.,Shen Tong,Wei Yong,Chen Ling,Brenner Lisa,Shiels Donna,Jensen Rhonda R.,Berger Michael,Mrozek Ewa,Ramaswamy Bhuvaneswari,Grever Michael,Au Jessie L.,Wientjes M. Guillaume,Shapiro Charles L.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference38 articles.
1. Song S, Wientjes MG, Gan Y, Au JL (2000) Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs. Proc Natl Acad Sci USA 97(15):8658–8663. doi: 10.1073/pnas.140210697
2. Gan Y, Wientjes MG, Au JL (2006) Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors. Pharm Res 23(6):1324–1331. doi: 10.1007/s11095-006-0136-6
3. Zhang Y, Song S, Yang F, Au JL, Wientjes MG (2001) Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors. J Pharmacol Exp Ther 299(2):426–433
4. Song S, Yu B, Wei Y, Wientjes MG, Au JL (2004) Low-dose suramin enhanced paclitaxel activity in chemotherapy-naive and paclitaxel-pretreated human breast xenograft tumors. Clin Cancer Res 10(18 Pt 1):6058–6065. doi: 10.1158/1078-0432.CCR-04-0595
5. Song S, Wientjes MG, Walsh C, Au JL (2001) Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases. Cancer Res 61(16):6145–6150
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献